MARCIA CARLSON: Open Payments
NPI 1790143071 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,234 in 127 payments from 20 companies in 2025. Trend: 2023 $1,668 · 2024 $1,868 · 2025 $2,234
Food & beverage: $2,122Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $483 |
| Lundbeck LLC | 21 | $387 |
| Teva Pharmaceuticals USA, Inc. | 14 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $211 |
| Otsuka America Pharmaceutical, Inc. | 13 | $208 |
| Alkermes, Inc. | 9 | $154 |
| Axsome Therapeutics, Inc. | 6 | $120 |
| Supernus Pharmaceuticals, Inc. | 3 | $61 |
| Neos Therapeutics, LP | 3 | $50 |
| Biogen, Inc. | 2 | $44 |
Products named: REXULTI, VRAYLAR, CAPLYTA, ARISTADA, UZEDY, AUSTEDO XR, Sunosi, Qelbree.
Industry payments across NE — which companies pay providers there.
